The Surviving Sepsis Guidelines provide a suitableframework to guide therapy for the majority of patientswith septic shock [1]. Appropriate and timely antimicro-bial therapy, source control if indicated, fluid therapy,and targeted vasopressors remain the backbone of treat-ment. However, a small proportion of patients fail to re-spond to these measures and deteriorate precipitouslyinto refractory shock and progressive multi-organ fail-ure. This subgroup of patients is often poorly repre-sented in large randomised controlled trials investigatingthe efficacy of interventions in septic shock. As a result,there is little conclusive evidence to guide managementin this particular population.

Ver PDF

Jaime Pabón

Ver todo

Comentar

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *